Screening for Critical Congenital Heart Disease in Newborns
Dynamic Critical Congenital Heart Screening With Addition of Perfusion Measurements
- Age
- 0 Minutes – 21 Days
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 320 (estimated)
- Sponsor
- University of California, Davis · Other
This trial is looking for newborns under 22 days old who might have heart issues. Participants will undergo a special screening test to check for critical congenital heart disease.
You may be able to join if
- I am under 22 days old
- I am a newborn suspected of having congenital heart disease
- I am a newborn with suspected or confirmed critical congenital heart disease
- I am an asymptomatic newborn undergoing SpO2 screening for CCHD
You may not be able to join if
- I had an echocardiogram before joining the trial
- I am a newborn with only a patent ductus arteriosus or atrial septal defect without other defects
- I have had heart surgery or catheter treatment before joining the trial
- I am currently receiving vasoactive medications other than prostaglandin therapy
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThe purpose of this study is to implement and externally validate an inpatient ML algorithm that combines pulse oximetry features for critical congenital heart disease (CCHD) screening.
Loading trial locations…